|
[1]
|
任彪, 廖彬佑, 王建楠, 等. 奥密克戎(Omicron)变异株及其对口腔诊疗的潜在影响[J]. 四川大学学报(医学版), 2022, 53(2): 175-180.
|
|
[2]
|
WHO (2022) Coronavirus (COVID-19) Dashboard. https://covid19.who.int
|
|
[3]
|
吴俣, 刘珏, 刘民, 梁万年. 新型冠状病毒Omicron变异株的流行病学特征及防控研究[J]. 中国全科医学, 2022, 25(1): 14-19.
|
|
[4]
|
WHO (2021) Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern.
https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
|
|
[5]
|
今冬疫情又起, 但黎明的曙光已不再遥远[EB/OL]. http://www.CRNTT.com, 2022-01-21.
|
|
[6]
|
美国专家反驳“疫情终结论”: 奥秘克戎传越广, 下一个变种越早来[EB/OL].
https://new.qq.com/omn/20220118/20220118A0BLND00.html, 2022-01-19.
|
|
[7]
|
14秒就能人传人, 钟南山口中“传染性极强”的德尔塔毒株是怎么回事?[EB/OL].
http://finance.sina.com.cn/tech/csj/2021-07-29/doc-ikqciyzk8293182.shtml#~:text, 2021-12-09.
|
|
[8]
|
Burki, T.K. (2022) Omicron Variant and Booster COVID-19 Vaccines. The Lancet Respiratory Medicine, 10, E17.
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00559-2
|
|
[9]
|
新冠病毒又双叒变异! 加息进程受阻?[EB/OL].
https://finance.sina.com.cn/money/forex/forexinfo/20211129/docikyakumx0681628.shtm, 2021-11-28.
|
|
[10]
|
上海疫情已超52万人感染, 多为奥秘克戎BA.2和BA.2.2 [EB/OL].
https://cj.sina.com.cn/articles/view/1643971635/61fd043300100xa47?finpagefr=p_104, 2022-4-29.
|
|
[11]
|
徐本锦, 宣焱, 杜淼, 等. 新冠病毒刺突糖蛋白结构与功能的生物信息学分析及原核表达[J]. 病毒学报, 2022, 38(1): 41-56.
|
|
[12]
|
何金娇, 刘洋洋, 毛雪飞, 等. SARS-CoV-2 S蛋白结构与功能的生物信息学分析[J]. 基因组学与应用生物学, 2021, 40(Z1): 2346-2355.
|
|
[13]
|
王嘉君. 浅谈Omicron新型冠状病毒变异株的特点和防控措施[J]. 福建轻纺, 2022(2): 33-37.
|
|
[14]
|
Li, Q., Guan, X., Wu, P., et al. (2020) Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. New England Journal of Medicine, 382, 1199-1207.
|
|
[15]
|
Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506. [Google Scholar] [CrossRef]
|
|
[16]
|
南非卫生部: 奥密克戎毒株或致新冠二次感染风险增加[EB/OL].
http://www.news.cn/world/2021-12/11/c_1128153618.htm, 2021-12-12.
|
|
[17]
|
Wrapp, D., Wang, N., Corbett, K.S., et al. (2020) Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science, 367, 1260-1263. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Astuti, I. (2020) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An Overview of Viral Structure and Host Response. Diabetes & Metabolic Syndrome: Clinical Re-search & Reviews, 14, 407-412. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Kumar, S. and Saxena, S.K. (2021) Structural and Molecular Perspec-tives of SARS-CoV-2. Methods, 195, 23-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Rodríguez-Maldonado, A.P., Vázquez-Pérez, J.A., Cedro-Tanda, A., et al. (2021) Emergence and Spread of the Potential Variant of Interest (VOI) B.1.1.519 of SARS-CoV-2 Predomi-nantly Present in Mexico. Archives of Virology, 166, 3173-3177. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Shang, J., Ye, G., Shi, K., et al. (2020) Structural Basis of Re-ceptor Recognition by SARS-CoV-2. Nature, 581, 221-224. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Qin, S., Cui, M., Sun, S., et al. (2021) Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529). Zoonoses, 1, 1-5. [Google Scholar] [CrossRef]
|
|
[23]
|
穆雪纯, 李丽, 王凌航. 新型冠状病毒流行变异株的分型及研究进展[J]. 国际病毒学杂志, 2021, 28(4): 336-340.
|
|
[24]
|
Frampton, D., Rampling, T., Cross, A., et al. (2021) Genomic Characteristics and Clinical Effect of the Emergent SARS-CoV-2 B.1.1.7 Lineage in London, UK: A Whole-Genome Sequencing and Hospital-Based Cohort Study. The Lancet Infectious Diseases, 21, 1246-1256. [Google Scholar] [CrossRef]
|
|
[25]
|
Liu, Y., Liu, J., Plante, K.S., et al. (2022) The N501Y Spike Substitution Enhances SARS-CoV-2 Transmission. Nature, 602, 294-299. [Google Scholar] [CrossRef] [PubMed]
|